Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Efficacy of Risankizumab versus Secukinumab in Patients with Moderate-to-Severe Psoriasis: Subgroup Analysis from the IMMerge Study Dermatology and Therapy February 2022;12(2):561-575

Date

02/01/2022

DOI

10.1007/s13555-021-00679-6

Scopus ID

2-s2.0-85123243722 (requires institutional sign-in at Scopus site)   7 Citations

Author List

Crowley JJ, Langley RG, Gordon KB, Pinter A, Ferris LK, Rubant S, Photowala H, Xue Z, Wu T, Zhan T, Beeck S, Shah M, Warren RB

Author

Kenneth Brian Gordon MD Chair, Professor in the Dermatology department at Medical College of Wisconsin